Coronary Artery Aneurysm
Symptoms, Doctors, Treatments, Advances & More

Coronary Artery Aneurysm Overview

Save information for later
Sign Up

Learn About Coronary Artery Aneurysm

What is the definition of Coronary Artery Aneurysm?
Coronary artery aneurysm (ballooning of arterial wall; CAA) is a rare condition. The function of the coronary arteries is to provide oxygen to the heart muscle. Coronary artery aneurysm most often occurs in adults with atherosclerosis (hardened, fatty build-up on artery walls) and children with Kawasaki disease (inflammation of arteries).
What are the symptoms of Coronary Artery Aneurysm?
Symptoms of coronary artery aneurysm may include episodes of chest pain (stable angina) upon exertion, low blood pressure, abnormal heart rhythms, heart attack, blood clots, heart failure, and sudden cardiac death.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Coronary Artery Aneurysm?
Treatment for coronary artery aneurysm may include medications, such as anticoagulants (aspirin, warfarin, intravenous eptifibatide, or heparin), antiplatelets (clopidogrel, prasugrel, or ticagrelor), and losartan, percutaneous coronary intervention with stent implantation or coil embolization, or surgery.
Who are the top Coronary Artery Aneurysm Local Doctors?
Elite in Coronary Artery Aneurysm
Elite in Coronary Artery Aneurysm
Referral may be required
Suita, JP 

Etsuko Tsuda practices practicing medicine in Suita, Japan. Ms. Tsuda is rated as an Elite expert by MediFind in the treatment of Coronary Artery Aneurysm. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Coronary Artery Aneurysm, Kawasaki Disease, Vasculitis, Heart Bypass Surgery, and Coronary Artery Bypass Graft (CABG).

Elite in Coronary Artery Aneurysm
Dr. Kevin G. Friedman
Pediatric Cardiology
Elite in Coronary Artery Aneurysm
Dr. Kevin G. Friedman
Pediatric Cardiology
Referral may be required

Childrens Hospital Ophthalmology Foundation Inc

9 Hope Ave, 
Waltham, MA 
617-355-7366
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Kevin Friedman is a Pediatric Cardiologist practicing medicine in Waltham, Massachusetts. Dr. Friedman is rated as an Elite provider by MediFind in the treatment of Coronary Artery Aneurysm. He is also highly rated in 61 other conditions, according to our data. His clinical expertise encompasses Coronary Artery Aneurysm, Kawasaki Disease, Multisystem Inflammatory Syndrome in Children (MIS-C), Embolectomy, and Heart Transplant. Dr. Friedman is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Coronary Artery Aneurysm
Elite in Coronary Artery Aneurysm
Referral may be required
CHU Ste Justine, 
Montreal, QC, CA 

Nagib Dahdah practices practicing medicine in Montreal, Canada. Dahdah is rated as an Elite expert by MediFind in the treatment of Coronary Artery Aneurysm. They are also highly rated in 9 other conditions, according to our data. Their clinical expertise encompasses Kawasaki Disease, Coronary Artery Aneurysm, Vasculitis, Heart Bypass Surgery, and Percutaneous Coronary Intervention (PCI).

View All Doctors
What are the latest Coronary Artery Aneurysm Clinical Trials?
Progression, Management Strategies, and Risk Factors of Coronary Artery Aneurysms: A Multicenter, Retrospective Cohort Study
Progression, Management Strategies, and Risk Factors of Coronary Artery Aneurysms: A Multicenter, Retrospective Cohort Study
Enrollment Status: Recruiting
Publish Date: August 13, 2026

Summary: This study aimed to characterize the progression and risk fators of coronary artery aneurysms, and copmpare the outcomes across different management strategies

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Randomized Phase III Multicenter Trial Comparing the Efficacy and Safety of Anakinra Versus Intravenous Immunoglobulin (IVIG) Retreatment, in Patients With Kawasaki Disease Who Failed to Respond to Initial Standard IVIG Treatment
A Randomized Phase III Multicenter Trial Comparing the Efficacy and Safety of Anakinra Versus Intravenous Immunoglobulin (IVIG) Retreatment, in Patients With Kawasaki Disease Who Failed to Respond to Initial Standard IVIG Treatment
Who is this study for: Patients with Kawasaki disease who failed to respond to initial standard IVIG treatment
Enrollment Status: Recruiting
Publish Date: February 28, 2024
Intervention Type: Drug
Study Drugs: Anakinra, Immunoglobulin
Study Phase: Phase 3

Summary: Kawasaki disease (KD) is the most frequent vasculitis in younger children \<5years, and the first cause of acquired ischemic myocardiopathy in childhood. Exceptionally, KD may cause early death during the acute phase by myocardial infarction, but may compromise the long-term cardiovascular outcome by accelerating atherosclerotic disease. The incidence of KD is high in far-Eastern countries and Haw...

View All Clinical Trials